Caliway Announced EMA Orphan Drug Designation Granted to CBL-514 for Dercum’s Disease Treatment
Hand-out
Press Releases
November 12, 2024

Caliway Announced EMA Orphan Drug Designation Granted to CBL-514 for Dercum’s Disease Treatment

- CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum's disease treatment.

bradford

The Bradford Era

Local & Social